Equities
Outlook Therapeutics Eyes $500M U.S. Sales as LYTENAVA Launch Nears
CEO Bob Jahr outlines commercial rollout of FDA-approved bevacizumab eye formulation for wet AMD, with U.S. launch expected before end of 2026.
Tsakos Energy Navigation Ltd stock hits 52-week high at $46.59
Shares of the energy transportation company reached a 52-week high, reflecting strong performance and a 102.37% year-to-date gain.
P&G CEO Highlights Execution Focus Amid Commodity Pressures
Procter & Gamble’s CFO and CEO underscore operational turnarounds and R&D acceleration at Barclays’ consumer conference, amid Brent crude spikes and regional growth targets.
Growthpoint Reports FY2026 Payout Rise Amid Slowed Growth, Office Challenges Persist
Growthpoint Properties Limited raised its dividend payout ratio to 87.5% in FY2026 but saw slower growth in the second half of 2026, with office vacancies and funding costs weighing on its outlook.
Central Garden & Pet Announces $340M TRIXIE Acquisition, Strong Cash Position Amid Growth Strategy
The company highlights organic sales growth, restructuring efforts, and a strategic European expansion through a major pet supplies acquisition.
Macy’s Q2 2026 earnings beat forecasts but shares decline
Revenue growth and adjusted EPS exceeded expectations, yet stock fell premarket as analysts adjusted expectations for a full-year earnings outlook.
US equities and commodities face pre-market declines amid inflation fears, oil volatility
Dow Jones and Nasdaq pre-market losses signal further Wall Street weakness; copper prices retreat after record highs amid US import speculation.
SFS Confirms 2026 Outlook Ahead of Investor Day
Swiss metal processor SFS reaffirmed its full-year guidance, projecting 3-6% revenue growth and a 12-15% normalized EBIT margin, as it prepares for its biennial investor day on Thursday.
DAX Expected Lower Open Amid Oil Prices, AI Concerns
Frankfurt opens in negative territory as oil climbs on Gulf tensions and new AI safety warnings weigh on tech-sensitive indices.
BofA rates Aviva and Admiral Group as buys, cites attractive UK insurance yields
Bank of America reinstated coverage of the UK insurance sector, noting dividend yields of 4.8%‑7.6% versus 3.3% for the broader market and recommending Aviva and Admiral Group as buy candidates.
COMP360 nears launch as COMPASS Pathways eyes 2027 market entry
Compass Pathways’ synthetic psilocybin treatment faces regulatory hurdles but aims to compete with Johnson & Johnson’s SPRAVATO in treatment-resistant depression.
Cicor secures €30m in European defense electronics contracts
The Swiss electronics supplier has landed major orders for microelectronics assembly in large-scale European defense and aerospace programs, expanding its client base to 16 of Europe’s top 20 defense firms.
DAX seen modestly higher ahead of US rate decision
The X-Dax out-of-hours indicator pointed to a 0.4% gain at 25,497 points as markets await Wednesday's Fed rate call.
Dax und EuroStoxx 50 steigen nach Fed-Zinserhöhung und Ölpreisdruck
Der deutsche Aktienmarkt und europäische Leitindizes profitierten von der Fed-Zinserhöhung und sinkenden Ölpreisen, während Branchen wie Autokonzern und Molekulardiagnostik besonders stark performten.
European stocks extend recovery on oil decline and US gains
EuroStoxx 50 rose 0.90%, FTSE 100 gained 1.19%, and the SMI climbed 0.57% as investors rotated into industrials and away from energy.
Jyske Bank Buys Back 51,815 Shares Worth 56.7 Million Kroner
Danish lender repurchased shares between Sept. 7-11 at an average price of 1,094.16 kroner, pushing its buyback program to nearly 1.86 billion kroner.
Blencowe Resources Drops Ex-CEO Ralston, Equity Awards Lapse After PDMR Review
Blencowe Resources terminates former CEO Mr Ralston's consultant engagement and declares his performance shares and options lapsed following a governance review over PDMR notification matters.
German equities fall after ECB raises interest rates
The DAX lost 0.7% to 25,407 points, marking its lowest point of the day, as markets reacted to the ECB's second rate hike of the year and revised inflation forecasts.
Wall Street erwartet weitere Verluste mit Fed-Fokus auf Zinsen und Inflation
US-Indizes zeigen schwache Entwicklung, während Ölpreise und Nahost-Konflikt die Stimmung belasten. Quartalszahlen von Tech- und Konsumgüterfirmen zeigen gemischte Ergebnisse.
SMI leitet sich mit Logitech an – US-Märkte profitieren von Fed-Unabhängigkeit und sinkenden Ölpreisen
Der Swiss Market Index schloss mit einem Plus von 0,6 Prozent, während US-Börsen nach der Fed-Zinserhöhung und fallenden Rohstoffpreisen wieder aufholten.
SoftBank Shares Drop 11% After OpenAI Rejects 2026 IPO Plans
SoftBank Group Corp. shares fell over 11% on Monday after OpenAI CEO Sam Altman stated the company will not pursue a public listing in 2026. The Nikkei 225 also declined 2%.
DWS Breaks Swiss ETF Asset Management Milestone at 100 Billion CHF
Swiss ETF assets under management by DWS Group exceed 100 billion CHF, reflecting rapid growth in passive investment products.
Cue Biopharma reports positive Phase 2 results for CUE-221
Cue Biopharma announced positive Phase 2 trial results for its CUE-221 candidate, with no additional details released at this time.
Swiss and US markets rise on Fed independence, Logitech leads SMI
Swiss indices closed higher on Thursday, with Logitech leading gains, while US markets benefited from falling oil prices and the Fed’s commitment to inflation control.